ARCHIVES

FDA Advisors Recommend Use of Cytokines GM-CSF, G-CSF In BMT And Chemotherapy

This article is from The Cancer Letter archive.

Vol. 17 No. 01 | January 4, 1991

Download PDF Visit The Full Archive

Related Articles

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

June 27, 2014

House Appropriations Boosts NIH By $1 Billion In Draft Budget That Cuts Other HHS Programs

September 30, 2011

NCI Moves Ahead To Find “Less-Hazardous” Cigarette

April 19, 1974

NRC considering “Escalated” Enforcement Action Against NIH

February 2, 1996

NCI Seeks Prevention Fellows.

March 9, 2001

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004